Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
- Status
- COMPLETED
- Phase
- PHASE3
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of-Function Mutations (GOFm) of the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene or Loss-of-Function Mutations (LOFm) of the Apolipoprotein (Apo) B Gene
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Aflibercept Injection for Radiation Retinopathy
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Study for Recalcitrant Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
IL1-TRAP, Rilonacept, in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
- Status
- COMPLETED
- Phase
- PHASE3